M Holdings Securities Inc. Takes $995,000 Position in Medtronic PLC $MDT

M Holdings Securities Inc. acquired a new stake in Medtronic PLC (NYSE:MDT) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 11,546 shares of the medical technology company’s stock, valued at approximately $995,000.

Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Medtronic by 1.5% in the 2nd quarter. Vanguard Group Inc. now owns 126,909,406 shares of the medical technology company’s stock valued at $11,062,693,000 after purchasing an additional 1,895,165 shares during the period. Geode Capital Management LLC raised its position in shares of Medtronic by 1.1% in the second quarter. Geode Capital Management LLC now owns 28,227,006 shares of the medical technology company’s stock worth $2,448,699,000 after buying an additional 310,684 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Medtronic by 2.9% during the second quarter. Bank of New York Mellon Corp now owns 21,275,850 shares of the medical technology company’s stock valued at $1,854,616,000 after buying an additional 595,549 shares during the period. Deutsche Bank AG grew its position in Medtronic by 3.1% during the first quarter. Deutsche Bank AG now owns 19,009,795 shares of the medical technology company’s stock worth $1,708,220,000 after buying an additional 566,155 shares in the last quarter. Finally, Invesco Ltd. increased its stake in Medtronic by 3.9% in the 2nd quarter. Invesco Ltd. now owns 17,647,149 shares of the medical technology company’s stock worth $1,538,302,000 after acquiring an additional 666,557 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

MDT has been the subject of a number of research analyst reports. The Goldman Sachs Group set a $111.00 price target on Medtronic and gave the company a “neutral” rating in a research report on Wednesday, November 19th. Cowen reaffirmed a “buy” rating on shares of Medtronic in a research note on Friday, November 14th. Argus lifted their target price on shares of Medtronic from $105.00 to $115.00 and gave the company a “buy” rating in a research report on Tuesday, August 26th. Piper Sandler reissued a “neutral” rating on shares of Medtronic in a research note on Friday, November 14th. Finally, UBS Group raised their price objective on shares of Medtronic from $95.00 to $102.00 and gave the company a “neutral” rating in a research report on Wednesday, November 19th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and twelve have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Medtronic currently has an average rating of “Moderate Buy” and a consensus target price of $110.44.

Medtronic Stock Down 0.0%

Shares of NYSE MDT opened at $101.93 on Friday. Medtronic PLC has a one year low of $79.29 and a one year high of $106.33. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.42 and a quick ratio of 1.80. The firm’s 50 day simple moving average is $96.65 and its two-hundred day simple moving average is $92.08. The stock has a market capitalization of $130.68 billion, a P/E ratio of 27.47, a PEG ratio of 2.69 and a beta of 0.71.

Medtronic (NYSE:MDT) last announced its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The firm had revenue of $8.96 billion during the quarter, compared to analyst estimates of $8.86 billion. During the same period in the previous year, the business posted $1.26 EPS. The business’s quarterly revenue was up 6.6% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. As a group, analysts expect that Medtronic PLC will post 5.46 EPS for the current fiscal year.

Medtronic Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 16th. Shareholders of record on Friday, December 26th will be given a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 2.8%. The ex-dividend date is Friday, December 26th. Medtronic’s dividend payout ratio is presently 76.55%.

Medtronic Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.